Joshua Makower, 10% Owner at Trevi Therapeutics, Inc. (TRVI), bought 4,438,562 shares at $10.00 ($25.0M) on 2019-05-09, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,938,562 | $0 | 0.0% |
| 2 | $10.00 | 1,000,000 | $10.0M | 40.0% |
| 3 | $10.00 | 1,500,000 | $15.0M | 60.0% |
| Total | $5.63 avg | 4,438,562 | $25.0M | 100% |
| Filing → |
| MRKR | BUY | 2021-03-18 | $20.0M | — | Filing → |
| RGLS | BUY | 2020-12-07 | $5.5M | — | Filing → |
| EAR | BUY | 2020-10-22 | $5.6M | — | Filing → |